EDGEWELL PERSONAL CARE COMPANY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.46 USD | -0.03% |
|
-4.06% | -3.19% |
| Apr. 12 | Barclays Cuts Price Target on Edgewell Personal Care to $37 From $39, Maintains Equalweight Rating | MT |
| Mar. 07 | Razor maker Harry's files for IPO, sources say | RE |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company has a low valuation given the cash flows generated by its activity.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The group shows a rather high level of debt in proportion to its EBITDA.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -3.19% | 1.77B | B | ||
| +6.42% | 366B | C- | ||
| -1.47% | 118B | B- | ||
| +8.10% | 70.83B | A+ | ||
| -16.61% | 61.75B | A- | ||
| -6.37% | 49.2B | B+ | ||
| -11.24% | 36.63B | - | ||
| -1.36% | 31.93B | B- | ||
| -0.36% | 16.14B | A- | ||
| +4.07% | 14.42B | B |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- EPC Stock
- Ratings Edgewell Personal Care Company
